149 related articles for article (PubMed ID: 16713270)
1. Synthesis and evaluation of acridine- and acridone-based anti-herpes agents with topoisomerase activity.
Goodell JR; Madhok AA; Hiasa H; Ferguson DM
Bioorg Med Chem; 2006 Aug; 14(16):5467-80. PubMed ID: 16713270
[TBL] [Abstract][Full Text] [Related]
2. 1,3-Dihydroxyacridone derivatives as inhibitors of herpes virus replication.
Akanitapichat P; Lowden CT; Bastow KF
Antiviral Res; 2000 Feb; 45(2):123-34. PubMed ID: 10809021
[TBL] [Abstract][Full Text] [Related]
3. Anti-herpes simplex virus activity of substituted 1-hydroxyacridones.
Lowden CT; Bastow KF
J Med Chem; 2003 Nov; 46(23):5015-20. PubMed ID: 14584951
[TBL] [Abstract][Full Text] [Related]
4. Effect of acridine derivatives on the multiplication of herpes simplex virus.
Mucsi I; Molnár J; Tanaka M; Santelli-Rouvier C; Patelis AM; Galy JP; Barbe J
Anticancer Res; 1998; 18(4C):3011-5. PubMed ID: 9713501
[TBL] [Abstract][Full Text] [Related]
5. Novel tetra-acridine derivatives as dual inhibitors of topoisomerase II and the human proteasome.
Vispé S; Vandenberghe I; Robin M; Annereau JP; Créancier L; Pique V; Galy JP; Kruczynski A; Barret JM; Bailly C
Biochem Pharmacol; 2007 Jun; 73(12):1863-72. PubMed ID: 17391647
[TBL] [Abstract][Full Text] [Related]
6. Novel trifluoromethylated 9-amino-3,4-dihydroacridin-1(2H)-ones act as covalent poisons of human topoisomerase IIα.
Infante Lara L; Sledge A; Laradji A; Okoro CO; Osheroff N
Bioorg Med Chem Lett; 2017 Feb; 27(3):586-589. PubMed ID: 27998679
[TBL] [Abstract][Full Text] [Related]
7. A Review on Acridines as Antiproliferative Agents.
Baliwada A; Rajagopal K; Varakumar P; Raman K; Byran G
Mini Rev Med Chem; 2022; 22(21):2769-2798. PubMed ID: 35546777
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships for substituted bis(acridine-4-carboxamides): a new class of anticancer agents.
Gamage SA; Spicer JA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
J Med Chem; 1999 Jul; 42(13):2383-93. PubMed ID: 10395479
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of cytotoxicity of N-[2-(dimethylamino)ethyl] acridine-4-carboxamide and of its 7-chloro derivative: the roles of topoisomerases I and II.
Bridewell DJ; Finlay GJ; Baguley BC
Cancer Chemother Pharmacol; 1999; 43(4):302-8. PubMed ID: 10071981
[TBL] [Abstract][Full Text] [Related]
10. From amsacrine to DACA (N-[2-(dimethylamino)ethyl]acridine-4-carboxamide): selectivity for topoisomerases I and II among acridine derivatives.
Finlay GJ; Riou JF; Baguley BC
Eur J Cancer; 1996 Apr; 32A(4):708-14. PubMed ID: 8695277
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of DNA topoisomerases I and II and growth inhibition of HL-60 cells by novel acridine-based compounds.
Janočková J; Plšíková J; Kašpárková J; Brabec V; Jendželovský R; Mikeš J; Kovaľ J; Hamuľaková S; Fedoročko P; Kuča K; Kožurková M
Eur J Pharm Sci; 2015 Aug; 76():192-202. PubMed ID: 25960253
[TBL] [Abstract][Full Text] [Related]
12. New spiro-acridines: DNA interaction, antiproliferative activity and inhibition of human DNA topoisomerases.
Almeida SM; Lafayette EA; Silva WL; Lima Serafim V; Menezes TM; Neves JL; Ruiz AL; Carvalho JE; Moura RO; Beltrão EI; Carvalho Júnior LB; Lima MD
Int J Biol Macromol; 2016 Nov; 92():467-475. PubMed ID: 27435006
[TBL] [Abstract][Full Text] [Related]
13. Acridine derivatives as inhibitors/poisons of topoisomerase II.
Kozurkova M
J Appl Toxicol; 2022 Apr; 42(4):544-552. PubMed ID: 34514603
[TBL] [Abstract][Full Text] [Related]
14. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2.
Chono K; Katsumata K; Kontani T; Kobayashi M; Sudo K; Yokota T; Konno K; Shimizu Y; Suzuki H
J Antimicrob Chemother; 2010 Aug; 65(8):1733-41. PubMed ID: 20534624
[TBL] [Abstract][Full Text] [Related]
15. Novel acridine-based compounds that exhibit an anti-pancreatic cancer activity are catalytic inhibitors of human topoisomerase II.
Oppegard LM; Ougolkov AV; Luchini DN; Schoon RA; Goodell JR; Kaur H; Billadeau DD; Ferguson DM; Hiasa H
Eur J Pharmacol; 2009 Jan; 602(2-3):223-9. PubMed ID: 19071108
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of glycoporphyrin derivatives and their antiviral activity against herpes simplex virus types 1 and 2.
Tomé JP; Neves MG; Tomé AC; Cavaleiro JA; Mendonça AF; Pegado IN; Duarte R; Valdeira ML
Bioorg Med Chem; 2005 Jun; 13(12):3878-88. PubMed ID: 15911304
[TBL] [Abstract][Full Text] [Related]
17. Structure based molecular design, synthesis and biological evaluation of α-pyrone analogs as anti-HSV agent.
Karampuri S; Bag P; Yasmin S; Chouhan DK; Bal C; Mitra D; Chattopadhyay D; Sharon A
Bioorg Med Chem Lett; 2012 Oct; 22(19):6261-6. PubMed ID: 22921079
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of novel substituted 2-phenylpyrazolopyridines with potent activity against herpesviruses.
Gudmundsson KS; Johns BA; Wang Z; Turner EM; Allen SH; Freeman GA; Boyd FL; Sexton CJ; Selleseth DW; Moniri KR; Creech KL
Bioorg Med Chem; 2005 Sep; 13(18):5346-61. PubMed ID: 16039862
[TBL] [Abstract][Full Text] [Related]
19. New acridone inhibitors of human herpes virus replication.
Bastow KF
Curr Drug Targets Infect Disord; 2004 Dec; 4(4):323-30. PubMed ID: 15578973
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and anti-BVDV activity of acridones as new potential antiviral agents.
Tabarrini O; Manfroni G; Fravolini A; Cecchetti V; Sabatini S; De Clercq E; Rozenski J; Canard B; Dutartre H; Paeshuyse J; Neyts J
J Med Chem; 2006 Apr; 49(8):2621-7. PubMed ID: 16610805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
